People · Operator
Named in public records as an officer, director or promoter · active 2017–2019 · Pharma, Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Verseau Therapeutics, Inc. | — | Pharma | Series A | $4.3M | $133.2M | 2017 |
| Combined Therapeutics, Inc. | — | Biotechnology | Pre-Seed | $250K | $13.8M | 2017 |
| Nininger Medical, Inc. | — | Biotechnology | Pre-Seed | $178K | $9.8M | 2019 |
Daniel Anderson at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Daniel Anderson on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Robert Langer | 2 | 36 |
| Christine Bunt | 1 | 4 |
| Justine Ryan | 1 | 1 |
| Romain Micol | 1 | 1 |
| Pierre Matussiere | 1 | 1 |
| Walter Capone | 1 | 1 |
| Jong Chang | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.